Dr Morena Makhoana joined Biovac in 2004 and holds the role of Chief Executive Officer. He is a member of the Board and the Biovac Executive team. His mandate is to realise the objective of building vaccine manufacturing capacity in Southern Africa.
During Morena’s tenure, Biovac has secured three successful technology transfers with global pharmaceutical companies such as Sanofi and Pfizer that has allowed the company to grow its staff complement from 24 to over 400.
Morena is a medical graduate from the University of Cape Town (UCT) in South Africa and has participated in numerous executive and business courses at both Harvard and Stanford Universities. Prior to his CEO role at Biovac he held the role of Deputy CEO and prior to that of Medical Affairs Director for Biovac.
He serves on a number of committees within the vaccine industry and serves as a board member of other healthcare and non-healthcare companies.
